Final Programme - iuphar

FC10 Drugs for half the world: Paediatric clinical
pharmacology
Wed 001 Risk factors for abnormal newborn hearing in the era of extended dose interval amikacin administration
Karel Allegaert, (Belgium), K Kneepkens, K Vandendriessche, F Debruyne, M Rayyan, G Naulaers,
C Desloovere
Wed 002 Does the need for domperidone administration shortly after delivery affect the duration breastfeeding
after preterm delivery?
Karel Allegaert, (Belgium), G Bosmans, M Vanhaver, V Cossey, A Debeer, C Vaanhole, K Janssens
Wed 003 Population pharmacokinetics study of benznidazole in children with Chagas disease
Jaime Altcheh, (Argentina), G Moscatelli, G Mastrantonio, S Moroni, N Giglio, G Koren, H Freilij,
F Garcia-Bournissen
Wed 004 Bioavailability and bioequivalence of three different sirup formulations cefeleksine at children in therapy
of severe tonsillitis
Adnan Bajraktarevic, (Bosnia Herzegovina), J Musabegovic, T Frankic, H Sladic, D Abduzaimovic
Wed 005 Graphic and pictorial tables explaining drug’s routes administration reduce the anxiety of the
hospitalized children in the intensive care unit.
MV Bellido, Inmaculada Bellido, (Spain), A Gomez-Luque
Wed 006 EUROPain – European pain audit in neonates – NeoOpioid Consortium
Lena Bergqvist, (Sweden), M Eriksson, KJS Anand, EM Boyle, H Lagercrantz, S Andersson, G Menon,
B van Overmeire, M Keller, L Hellström-Westas, V Fellman, RHN van Schaik, J-P Osselaere, A Rane,
J Schollin, R Carbajal
Wed 007 Drugs use in paediatric population. Evaluation in two areas: Neonatology and intensive care units
Encarnación Blanco, (Spain), I Bellido, EI Márquez, A Medina, JA González-Correa
Wed 008 Documentation of recent drug history in children visiting a pediatric emergency clinic
Ylva Böttiger, (Sweden), E Kimland, S Lindemalm
Wed 009 Diagnosis and treatment of seizures in the neonatal intensive care unit
N Cosic-Cerovac, Milca Prostran-Veselinovic, (Republic of Serbia), N Jovic, R Stojanovic, Z Stojanovic
Wed 010 Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome.
A case report
Silvia De Francia, (Italy), E Pirro, E Banaudi, C Riggi, F De Martino, F Piccione, F Di Carlo
Wed 011 Nephrotic syndrome in children: Genetic variability of the clinical presentation and therapeutic response
Valery Elie, (France), M Fakhoury, Y Medard, A Rousseau, G Deschenes, E Jacqz-Aigrain
Wed 012 CANCELLED
Wed 013 N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children;
translational pharmacokinetics
Lauren Hanly, (Canada), N Chen, B Baw, B Malkin, M Culter, D Freeman, M Rieder, G Koren
Wed 014 Expression of cytochrome P450 metabolizing enzymes depends on gestational age in critically ill
preterm infants
Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson
Wed 015 Modulation of gene expression in critically ill preterm infants following stress
Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson
Wed 016 Genotype-specific pharmacodynamics in BH4 responsive phenylketonuria
Florian B Lagler, (Austria), C Zsifkovits, SW Gersting, R Fingerhut, H Glossmann, C Muntau
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 245